Get the Stockscreener App
227.50
0.53%
-1.21
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $227.50, with a volume of 1.66M.
It is down -0.53% in the last 24 hours and up +1.49% over the past month.
See More
Previous Close:
$228.71
Open:
$228.62
24h Volume:
1.66M
Relative Volume:
0.90
Market Cap:
$66.11B
Revenue:
$20.64B
Net Income/Loss:
$1.73B
P/E Ratio:
37.79
EPS:
6.02
Net Cash Flow:
$2.94B
1W Performance:
-1.19%
1M Performance:
+1.49%
6M Performance:
-5.80%
1Y Performance:
-8.06%
1-Day Range:
$226.25
$229.00
1-Week Range:
$226.25
$231.82
52-Week Range:
$218.75
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
227.50 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ISRG
Intuitive Surgical Inc
|
491.84 | 181.97B | 8.35B | 2.32B | 1.30B | 6.41 |
|
ALC
Alcon Inc
|
95.77 | 47.37B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.94 | 32.31B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
33.75 | 17.31B | 17.28B | 108.00M | 391.00M | 0.20 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
BD Names Gregory J. Hayes to Board of Directors - Quantisnow
Goldman Sachs Adjusts PT on Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - Marketscreener.com
Goldman Sachs Adjusts PT to Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - Marketscreener.com
Was Jim Cramer Right About Becton, Dickinson and Company (BDX)? - Insider Monkey
Insider Sell: Richard Byrd Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus.com
FDA tags Becton, Dickinson and Company infusion software recall as Class I - Yahoo Finance
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Becton Dickinson and : BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance - Marketscreener.com
Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial -March 20, 2025 at 07:56 am EDT - Marketscreener.com
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery - Quantisnow
Becton, Dickinson and Company Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE? Scaffold in Breast Implant Revision Surgery - Marketscreener.com
Becton Dickinson EVP Richard Byrd sells $105,570 in stock By Investing.com - Investing.com Australia
Becton Dickinson EVP Richard Byrd sells $105,570 in stock - Investing.com
SEC Form 144 filed by Becton Dickinson and Company - Quantisnow
Here's Why Becton Dickinson (BDX) is a Strong Momentum Stock - Yahoo Finance
How Do Investors Really Feel About Becton Dickinson? - Benzinga
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Becton, Dickinson, And Company Stock: Is BDX Underperforming The Healthcare Sector? - Barchart
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector? - Inkl
Becton, Dickinson and Company (NYSE:BDX) Stock Price Down 0.3% Following Insider Selling - Defense World
Becton Dickinson EVP Richard Byrd sells $436,325 in stock By Investing.com - Investing.com South Africa
BD to acquire Bard - Covington News
Becton Dickinson EVP Richard Byrd sells $436,325 in stock - Investing.com India
Becton Dickinson Says Ex-Exec Broke Non-Compete, Stole Secrets - Bloomberg Law
Becton Dickinson at Barclays Conference: Strategic Medtech Shift By Investing.com - Investing.com Canada
Becton Dickinson at Barclays Conference: Strategic Medtech Shift - Investing.com
Fisher Asset Management LLC Has $202,000 Stake in Becton, Dickinson and Company (NYSE:BDX) - Defense World
Dividend Aristocrats In Focus: Becton, Dickinson & Co. - Sure Dividend
Becton, Dickinson and Company (NYSE:BDX) Upgraded at StockNews.com - Defense World
Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus.com
December 2026 Options Now Available For Becton, Dickinson (BDX) - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Stock Rating Lowered by StockNews.com - Defense World
BD East Africa, Safaricom to compensate ex-staff over privacy breach - Capital FM Kenya
BD Packaging Innovations Get Under Patients’ Skin - Packaging Digest
Head to Head Contrast: Universal Media Group (OTCMKTS:UMGP) vs. Becton, Dickinson and Company (NYSE:BDX) - Defense World
Argus Adjusts Becton Dickinson and Co.'s Price Target to $270 From $290 -February 21, 2025 at 10:39 am EST - Marketscreener.com
BD business separation could allow competitors to rise in IVD test markets - Medical Device Network
BD Recalls ChloraPrep Clear 1 ML Applicators - Nasdaq
Becton, Dickinson and Company's SWOT analysis: med tech giant's stock poised for growth - Investing.com India
Do Wall Street Analysts Like Becton, Dickinson and Company Stock? - Inkl
Do Wall Street Analysts Like Becton, Dickinson And Company Stock? - Barchart
Becton Dickinson and : BD Announces Voluntary Worldwide Recall for One Lot of ChloraPrep™ Clear 1 mL Applicators Due to Fungal Contamination - Marketscreener.com
Chevy Chase Trust Holdings LLC Cuts Position in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
MADDEN SECURITIES Corp Invests $407,000 in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):